These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 66298)

  • 1. Substrate specificity of antinuclear antibodies in scleroderma.
    Blaszczyk M; Beutner EH; Rogozinski T; Rzesa G; Jarzabek-Chorzelska M; Jablonska S; Chorzelski TP
    J Invest Dermatol; 1977 Apr; 68(4):191-3. PubMed ID: 66298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue specificity of antinuclear antibodies in scleroderma.
    Błaszczyk M; Beutner EH; Rogoziński T; Rzesa G; Jarzabek-Chorzelska M; Jabłońska S; Chorzelski TP
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):761-4. PubMed ID: 107922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the complement-fixing activity of antinuclear antibodies in lupus nephritis, mixed connective tissue disease, and scleroderma.
    Parker MD; Turner RA
    Arthritis Rheum; 1976; 19(5):857-61. PubMed ID: 786297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of systemic lupus erythematosus. Importance of antinuclear antibody titers and peripheral staining patterns.
    Nisengard RJ; Jablonska S; Chorzelski TP; Blaszcyk M; Jarret C; Beutner EH
    Arch Dermatol; 1975 Oct; 111(10):1298-300. PubMed ID: 54050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human fibroblasts, a convenient nuclear substrate for detection of anti-nuclear antibodies including anti-centromere antibodies.
    Kallenberg CG; van der Meulen J; Pastoor GW; Snijder JA; Feltkamp TE; The TH
    Scand J Rheumatol; 1983; 12(3):193-200. PubMed ID: 6414079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to native DNA in connective tissue disease. A comparison of radioimmunoassay, counterimmunoelectrophoresis and indirect immunofluorescence on Crithidia luciliae substrate.
    Hodinka L; Merétey K; Jancsó A; Falus A; Korda J; Bozsóky S
    Arch Immunol Ther Exp (Warsz); 1979; 27(5):641-6. PubMed ID: 398205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of mouse liver sections and cultured mouse fibroblasts as substrates for the detection of antinuclear antibodies.
    Lubiniecki AS
    Am J Clin Pathol; 1976 Nov; 66(5):892-8. PubMed ID: 790937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Range of antinuclear antibodies in "healthy" individuals.
    Tan EM; Feltkamp TE; Smolen JS; Butcher B; Dawkins R; Fritzler MJ; Gordon T; Hardin JA; Kalden JR; Lahita RG; Maini RN; McDougal JS; Rothfield NF; Smeenk RJ; Takasaki Y; Wiik A; Wilson MR; Koziol JA
    Arthritis Rheum; 1997 Sep; 40(9):1601-11. PubMed ID: 9324014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinuclear antibodies (ANA): immunologic and clinical significance.
    Fernandez-Madrid F; Mattioli M
    Semin Arthritis Rheum; 1976 Nov; 6(2):83-124. PubMed ID: 62398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed connective tissue disease in childhood. A clinical and serologic survey.
    Singsen BH; Bernstein BH; Kornreich HK; King KK; Hanson V; Tan EM
    J Pediatr; 1977 Jun; 90(6):893-900. PubMed ID: 300795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal nuclear immunofluorescence. Is it a specific marker for mixed connective tissue disease?
    Kent LT; Hu CH; Michel B; Tan EM; Moskowitz RW
    J Dermatol; 1984 Apr; 11(2):121-8. PubMed ID: 6384307
    [No Abstract]   [Full Text] [Related]  

  • 12. Symptomatology and diagnosis in connective tissue disease. Antibodies to extractable ribonucleoprotein in 123 patients reacting with cell nuclei in the immunofluorescence test.
    Jonsson J
    Scand J Rheumatol; 1976; 5(3):177-83. PubMed ID: 790556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crithidium luciliae immunofluorescence test (CL test) a simple and reliable method for detecting anti-native DNA antibodies.
    Jarzabek-Chorzelska M; Chorzelski T; Rzesa G; Błaszczyk M
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):791-4. PubMed ID: 373689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiles of antinuclear antibodies in systemic rheumatic diseases.
    Notman DD; Kurata N; Tan EM
    Ann Intern Med; 1975 Oct; 83(4):464-9. PubMed ID: 1080976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunofluorescence studies in progressive systemic sclerosis (scleroderma) and mixed connective tissue disease.
    Reimer G; Huschka U; Keller J; Kammerer R; Hornstein OP
    Br J Dermatol; 1983 Jul; 109(1):27-36. PubMed ID: 6344904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-nuclear antibodies in collagen diseases].
    Gintz B; Phelip X; Micouin C; Cabanel G
    Sem Hop; 1975 Feb; 51(9):573-80. PubMed ID: 169588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of native DNA antibodies in systemic lupus erythematosus and other connective tissue diseases.
    Webb J; Whaley K; Lee P
    Scott Med J; 1974 Jul; 19(4):171-5. PubMed ID: 4209789
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo antinuclear antibodies (ANA) in biopsies of normal skin: diagnostic significance and relation to serum ANA.
    Kallenberg CG; de Jong MC; Walstra TM; Kardaun S; The TH
    J Rheumatol; 1983 Oct; 10(5):733-40. PubMed ID: 6606041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
    Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G; Chorzelski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):765-8. PubMed ID: 312085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antinuclear, anticentromere and anti-ScL-70 antibodies in rheumatic diseases].
    Ivanova SM; Melkumova KL; Il'in KV; Riazantseva TA; Piven' VA; Speranskiĭ AI
    Lab Delo; 1990; (6):50-3. PubMed ID: 1699041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.